Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes

INTRODUCTION: Degludec (IDeg) is an ultralong-acting insulin, with stable pharmacodynamic profile which leads to lower fluctuations in glucose levels. The effect of IDeg has not been specifically assessed in patients with unstable diabetes, defined as increased glycemic variability (GV). METHODS: A...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Transl Endocrinol
Hlavní autoři: Henao-Carrillo, Diana Cristina, Muñoz, Oscar M., Gómez, Ana M., Rondón, Martín, Colón, Christian, Chica, L., Rubio, Claudia, León-Vargas, Fabián, Calvachi, Maria Alejandra, Perea, Ana María
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2018
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992319/
https://ncbi.nlm.nih.gov/pubmed/29892561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcte.2018.03.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky